高端疫苗
654746.90−0.65−1.37%收盤・資料日 2026-11-06
股期
每股盈餘左軸 EPS、右軸股價
2026 Q20.07 元—
單季 EPS（元）
202120222023202420252026
盈餘表新到舊
| 季別 | EPS（元） | 季增率 | 年增率 |
|---|---|---|---|
| 2026 Q2 | 0.07 | — | — |
| 2026 Q1 | −0.09 | — | — |
| 2026 Q1–Q2 合計 | −0.02 | — | |
| 2025 Q4 | −0.42 | — | — |
| 2025 Q3 | −0.07 | — | — |
| 2025 Q2 | −0.30 | — | −850.00% |
| 2025 Q1 | −0.06 | — | — |
| 2025 全年合計 | −0.85 | — | |
| 2024 Q4 | −0.06 | — | — |
| 2024 Q3 | 0.00 | −100.00% | — |
| 2024 Q2 | 0.04 | — | — |
| 2024 Q1 | −0.22 | — | — |
| 2024 全年合計 | −0.24 | — | |
| 2023 Q4 | −1.77 | — | — |
| 2023 Q3 | −0.16 | — | — |
| 2023 Q2 | −0.96 | — | — |
| 2023 Q1 | −0.65 | — | — |
| 2023 全年合計 | −3.54 | — | |
| 2022 Q4 | −2.21 | — | −144.02% |
| 2022 Q3 | −0.95 | — | −129.69% |
| 2022 Q2 | −1.44 | — | — |
| 2022 Q1 | −0.66 | −113.15% | — |
| 2022 全年合計 | −5.26 | −179.22% | |
| 2021 Q4 | 5.02 | +56.87% | — |
| 2021 Q3 | 3.20 | — | — |
| 2021 全年合計 | 6.64 | — |
三率
2026 Q281.55%18.58%19.43%
三率（%）
202120222023202420252026
三率明細單季
| 期間 | 毛利率 | 營益率 | 淨利率 |
|---|---|---|---|
| 2026 Q2 | 81.55% | 18.58% | 19.43% |
| 2026 Q1 | 74.74% | −30.12% | −26.75% |
| 2025 Q4 | 72.34% | −97.27% | −93.99% |
| 2025 Q3 | 39.94% | −13.40% | −10.98% |
| 2025 Q2 | 69.74% | −42.95% | −68.95% |
| 2025 Q1 | 65.04% | −28.48% | −18.23% |
| 2024 Q4 | 55.75% | −34.90% | −17.17% |
| 2024 Q3 | 57.31% | 3.56% | 0.62% |
| 2024 Q2 | 80.14% | −1.52% | 7.74% |
| 2024 Q1 | 76.66% | −182.08% | −125.28% |
| 2023 Q4 | 69.39% | −318.57% | −339.76% |
| 2023 Q3 | 51.00% | −39.85% | −23.84% |
| 2023 Q2 | — | — | — |
| 2023 Q1 | — | — | — |
| 2022 Q4 | <−999% | <−999% | <−999% |
| 2022 Q3 | 98.04% | <−999% | <−999% |
| 2022 Q2 | −38.21% | <−999% | <−999% |
| 2022 Q1 | 64.31% | −46.38% | −42.97% |
| 2021 Q4 | 70.46% | 51.66% | 52.50% |
| 2021 Q3 | 70.08% | 52.39% | 54.55% |
ROE 拆解每季都是近四季合計
2026 Q2近四季
ROE−4.70%−0.93 個百分點
＝淨利率−29.06%−6.67 個百分點
×總資產週轉0.14 次−0.01 次
×權益乘數1.19 倍+0.05 倍
ROA −4.19%。和 2025 Q2 比，ROE 減少。
2026 Q2−4.70%−4.19%
ROE、ROA（近四季合計，%）
202120222023202420252026
2026 Q2−29.06%
淨利率（近四季，%）
202120222023202420252026
2026 Q20.14 次
總資產週轉（近四季合計，次）
202120222023202420252026
2026 Q21.19 倍
權益乘數（倍）
202120222023202420252026
ROE 明細每季都是近四季合計
| 期間 | ROE | ROA | 淨利率 | 總資產週轉（次） | 權益乘數（倍） |
|---|---|---|---|---|---|
| 2026 Q2 | −4.70% | −4.19% | −29.06% | 0.14 | 1.19 |
| 2026 Q1 | −8.02% | −7.03% | −47.87% | 0.15 | 1.15 |
| 2025 Q4 | −7.76% | −6.87% | −45.94% | 0.15 | 1.14 |
| 2025 Q3 | −4.43% | −3.93% | −27.84% | 0.14 | 1.13 |
| 2025 Q2 | −3.77% | −3.34% | −22.39% | 0.15 | 1.14 |
| 2025 Q1 | −0.73% | −0.70% | −4.24% | 0.15 | 1.17 |
| 2024 Q4 | −2.11% | −1.43% | −13.29% | 0.13 | 1.22 |
| 2024 Q3 | −15.63% | −10.08% | −98.81% | 0.13 | 1.24 |
| 2024 Q2 | −16.83% | −10.90% | −111.32% | 0.10 | 1.46 |
| 2024 Q1 | −23.92% | — | — | 0.070 | — |
| 2023 Q4 | −26.31% | — | — | 0.060 | — |
| 2023 Q3 | −25.54% | — | — | 0.036 | — |
| 2023 Q2 | −29.70% | — | — | 0.003 | — |
| 2023 Q1 | −28.86% | — | — | 0.005 | — |
| 2022 Q4 | −27.57% | −20.41% | −403.95% | 0.067 | 1.01 |
| 2022 Q3 | 11.56% | 10.81% | 13.00% | 0.48 | 1.85 |
| 2022 Q2 | 37.98% | 30.48% | 35.89% | 0.77 | 1.37 |
| 2022 Q1 | 37.80% | 30.34% | 39.58% | 0.77 | 1.24 |
| 2021 Q4 | 35.74% | 28.50% | 42.98% | 0.71 | 1.17 |
| 2021 Q3 | 1.70% | 0.10% | 12.53% | 0.29 | 0.46 |
財經資料來源：FinLab